Suspect hepatitis vaccines sealed for investigation
Print Edition
The hepatitis B vaccines suspected of causing the death of two babies have been sealed for investigation, a manager of the company that produces them said.
The vaccines were produced by Biokangtai in Shenzhen, Guangdong Province.
The company produced 450,000 hepatitis B vaccines last year and the suspect ones came from two different batches, Southern Metropolis Daily reported, citing a Biokangtai manager.
The manager told the newspaper the bulk of the vaccines were sold to Hunan Province, where two babies have died after receiving a vaccination.
However, 3,600 vaccines were sold to Guangdong Province and some to Guizhou Province, the manager added.
In Guangdong, 190 vaccines had been used on infants in the city’s capital city of Guangzhou as of Saturday. Authorities there had not received any reports of sickness or deaths, the report said.
No suspect vaccines were sold to Shanghai.
The company was cited as saying the vaccines had not expired and there were no problems during production, storage or transportation.
Both the China Food and Drug Administration and Shenzhen’s drug watchdog were still investigating.
Vaccinations have been a key part of a successful national strategy to combat hepatitis in China, a practice that has been encouraged by the World Health Organization.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
